817 results on '"Bentivoglio, Anna Rita"'
Search Results
2. Oromandibular dystonia: from onset to spread a multicenter italian study
3. Does thyroid diseases contribute to the natural history of idiopathic adult-onset dystonia? Data from the Italian Dystonia Registry
4. Managing tremor in fragile X-associated tremor/ataxia syndrome with botulinum neurotoxin: report of a success
5. Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson’s disease
6. Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease
7. Differential profiles of serum cytokines in Parkinson's disease according to disease duration
8. Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study
9. Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up
10. Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease
11. Intraoperative microelectrode recording during asleep deep brain stimulation of subthalamic nucleus for Parkinson Disease. A case series with systematic review of the literature
12. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
13. Does sex influence the natural history of idiopathic adult-onset dystonia?
14. STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson’s disease
15. Botulinum toxin injection for the treatment of chronic anal fissure: uni- and multivariate analysis of the factors that promote healing
16. Geographic differences in the incidence of Huntington’s disease in Sardinia, Italy
17. Parkinson’s disease and virtual reality rehabilitation: cognitive reserve influences the walking and balance outcome
18. Movement disorders following mechanical thrombectomy resulting in ischemic lesions of the basal ganglia: An emerging clinical entity
19. Differential profiles of serum cytokines in Parkinson's disease according to disease duration
20. Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site
21. Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease
22. What about the caregiver? A journey into Parkinson’s disease following the burden tracks
23. Frameless stereotaxy in subthalamic deep brain stimulation: 3-year clinical outcome
24. Deep brain stimulation in Fragile X syndrome with tardive dystonia
25. Correction to: The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients
26. Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study
27. Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson’s disease
28. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
29. A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson’s disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study
30. Immediate effects of rhythmic auditory stimulation on gait kinematics in Parkinson’s disease ON/OFF medication
31. Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study
32. The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients
33. Phenotypic Variability in Acquired and Idiopathic Dystonia
34. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease
35. Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease
36. Long-Term Spasticity Management in Post-Stroke Patients: Issues and Possible Actions—A Systematic Review with an Italian Expert Opinion
37. Assessment of dopaminergic pathways in Huntington’s Disease: when, how, why? A (clinician-friendly) systematic review of the literature on PET and SPECT applications
38. Sleep-related modifications of EEG connectivity in the sensory-motor networks in Huntington Disease: An eLORETA study and review of the literature
39. Association of metabolic syndrome with falls in patients with Parkinson's disease
40. Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis.
41. Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study
42. Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation
43. Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD)
44. Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders
45. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview
46. Clinical differences between botulinum neurotoxin type A and B
47. Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up
48. D09 Exploring neurodegeneration and inflammation blood biomarkers in a cohort of italian patients with Huntington’s disease
49. F16 The progression of pathology in 4 years longitudinally monitored patients with late onset Huntington’s disease
50. F41 Comparison of affective and cognitive components of theory of mind in Huntington‘s and Parkinson‘s diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.